Advice
Following a full submission
alitretinoin (Toctino) is accepted for use within NHS Scotland in adults who have severe chronic hand eczema that is unresponsive to treatment with potent topical corticosteroids.
Evidence is limited to a randomised placebo-controlled study where alitretinoin was superior to placebo in terms of the primary endpoint, Physician Global Assessment of response.
It is recommended that alitretinoin is dispensed by a hospital-based pharmacy.
Download detailed advice86KB (PDF)
Medicine details
- Medicine name:
- alitretinion (Toctino)
- SMC ID:
- 538/09
- Indication:
- Severe chronic hand eczema
- Pharmaceutical company
- Basilea Pharmaceuticals Ltd
- BNF chapter
- Skin
- Submission type
- Full
- Status
- Accepted
- Date advice published
- 09 March 2009